Xolair Holds Up for Chronic Rhinosinusitis with Polyps

(MedPage Today) -- Omalizumab (Xolair) maintained efficacy for chronic rhinosinusitis with nasal polyps, a researcher reported.
In an open-label extension study of two, 24-week clinical trials, omalizumab was associated with significant improvements...